Biocryst Pharmaceuticals Inc
BioCryst Pharmaceuticals develops oral and injectable therapeutics for rare diseases, including hereditary angioedema.
10-KSep 28Latest SEC filing
Aug 5Latest story
Sign inSign inBioCryst Pharmaceuticals develops oral and injectable therapeutics for rare diseases, including hereditary angioedema.